SR 11302
Names
Biological Activity
[Description]:
SR 11302 is an activator protein-1 (AP-1) transcription factor inhibitor. SR 11302 is a retinoid that specifically inhibits AP-1 activity without activating the transcription of retinoic acid response element (RARE)[1].
[Related Catalog]:
[Target]
AP-1[1]
[In Vitro]
SR 11302 (SR11302) show strong anti-AP-1 activity with selective binding with RARα and RARγ, but not with RARβ and RXRα[1]. SR 11302 (SR-11302; 1 μM) inhibits AP-1 transcription factor activity and decreases aldosterone levels by 61.9% in hypoxia-treated cells[2]. SR 11302 (SR-11302; 2 µM; 48 hours) inhibits Helicobacter pylori (H. pylori)-induced cell proliferation in adenocarcinoma gastric (AGS) cells[3]. SR 11302 (2 µM; 24 hours) inhibits H. pylori-induced expression of β-catenin and c-myc in AGS cells[3].
[In Vivo]
SR 11302 (SR11302; low dose 0.5 mg/kg and high dose 1 mg/kg body weight; orally gavaged daily) treatment reduces the total vascular lesion number and lesion size in Vldlr-/- mice in a dose-dependent manner[4]. Animal Model: Vldlr-/- mice[4] Dosage: Low dose 0.5 mg/kg and high dose 1 mg/kg body weight Administration: Orally gavaged daily from P5 to P15 Result: High-dose from P5 to P15 reduced the total vascular lesion number by 48% and decreased the lesion size by 40%, without detectable signs of toxicity in mice, including no change in body weight.
[References]
Chemical & Physical Properties
[ Density]:
1.048g/cm3
[ Boiling Point ]:
541.567ºC at 760 mmHg
[ Molecular Formula ]:
C26H32O2
[ Molecular Weight ]:
376.53100
[ Flash Point ]:
414.977ºC
[ Exact Mass ]:
376.24000
[ PSA ]:
37.30000
[ LogP ]:
7.04830
[ Vapour Pressure ]:
0mmHg at 25°C
[ Index of Refraction ]:
1.587
Safety Information
[ Hazard Codes ]:
Xi